Education
About Us
Working with TipRanks
Follow Us
Tri Chemical Laboratories Inc. (JP:4369)
:4369
4369 Stock Chart & Stats
¥2710.00
¥180.00(5.79%)
At close: 4:00 PM EST
¥2710.00
¥180.00(5.79%)
Day’s Range― - ―
52-Week Range¥1,890.00 - ¥3,840.00
Previous CloseN/A
Volume786.90K
Average Volume (3M)842.32K
Market Cap
¥109.68B
Enterprise Value¥98.58B
Total Cash (Recent Filing)¥5.42B
Total Debt (Recent Filing)¥4.24B
Price to Earnings (P/E)19.5
Beta1.18
Next Earnings
Mar 13, 2026EPS Estimate
43.77Next Dividend Ex-DateN/A
Dividend Yield1.3%
Share Statistics
EPS (TTM)38.31
Shares Outstanding32,498,640
10 Day Avg. Volume589,290
30 Day Avg. Volume842,316
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)3.35
Price to Sales (P/S)5.60
P/FCF Ratio174.89
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)183.26
Revenue Forecast (FY)¥27.00B
Bulls Say, Bears Say
Bulls Say
High ProfitabilitySustained gross margins ~41-42% and a 24% net margin indicate durable pricing power and operational efficiency. These margins create a structural cushion against cost variation, support reinvestment and shareholder returns, and underpin resilient long-term cash generation potential.
Low LeverageVery low debt-to-equity (~0.047) and a strong ROE (17.64%) provide lasting financial flexibility. Low leverage reduces default risk, supports capital allocation choices, and enables the company to pursue growth or weather downturns without large interest burdens, a durable balance-sheet advantage.
Operational EfficiencyHealthy EBIT/EBITDA margins combined with positive revenue growth (2.17% TTM) reflect efficient operations and stable end-market demand. Consistent operational profitability supports reinvestment capacity and makes earnings less sensitive to short-term volume swings over the medium term.
Bears Say
Negative Free Cash FlowNegative free cash flow in the trailing twelve months and an operating-cash-to-net-income ratio of 0.36 signal weak cash conversion. Over several quarters this can constrain capital expenditure, limit dividend/repurchase flexibility, and force external financing for growth initiatives.
Margin Compression RiskA reported slight decline in gross margin year-over-year points to emerging cost or pricing pressure. If this trend persists, it could erode the company’s current profitability cushion, reducing ability to absorb higher input costs or fund incremental investments without margin recovery.
Rising Debt To MonitorAlthough leverage remains low, the noted uptick in debt from the prior year is a structural watch item. Continued increases, especially while free cash flow is negative, could impair financial flexibility, increase interest exposure, and weaken balance-sheet resilience over the medium term.
Tri Chemical Laboratories Inc. News
4369 FAQ
What was Tri Chemical Laboratories Inc.’s price range in the past 12 months?
Tri Chemical Laboratories Inc. lowest stock price was ¥1890.00 and its highest was ¥3840.00 in the past 12 months.
What is Tri Chemical Laboratories Inc.’s market cap?
Tri Chemical Laboratories Inc.’s market cap is ¥109.68B.
When is Tri Chemical Laboratories Inc.’s upcoming earnings report date?
Tri Chemical Laboratories Inc.’s upcoming earnings report date is Mar 13, 2026 which is in 4 days.
How were Tri Chemical Laboratories Inc.’s earnings last quarter?
Tri Chemical Laboratories Inc. released its earnings results on Nov 28, 2025. The company reported ¥38.31 earnings per share for the quarter, beating the consensus estimate of N/A by ¥38.31.
Is Tri Chemical Laboratories Inc. overvalued?
According to Wall Street analysts Tri Chemical Laboratories Inc.’s price is currently Overvalued.
Does Tri Chemical Laboratories Inc. pay dividends?
Tri Chemical Laboratories Inc. pays a Annually dividend of ¥35 which represents an annual dividend yield of 1.3%. See more information on Tri Chemical Laboratories Inc. dividends here
What is Tri Chemical Laboratories Inc.’s EPS estimate?
Tri Chemical Laboratories Inc.’s EPS estimate is 43.77.
How many shares outstanding does Tri Chemical Laboratories Inc. have?
Tri Chemical Laboratories Inc. has 32,498,640 shares outstanding.
What happened to Tri Chemical Laboratories Inc.’s price movement after its last earnings report?
Tri Chemical Laboratories Inc. reported an EPS of ¥38.31 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.108%.
Which hedge fund is a major shareholder of Tri Chemical Laboratories Inc.?
Currently, no hedge funds are holding shares in JP:4369
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Tri Chemical Laboratories Inc.
Tri Chemical Laboratories Inc. provides precursors for semiconductors, optical fibers, solar cells, and compound semiconductors. It also offers catalysts, special reagents, etc. In addition, the company provides containers, such as stainless-steel containers with valves, seamless cylinders for high pressure gas, glass ampoules, polyethylene bottles, glass bottles, and glass vial bottles. Tri Chemical Laboratories Inc. was incorporated in 1978 and is headquartered in Uenohara, Japan.
Technical Analysis
Sanyo Chemical Industries
―
Osaka Organic Chemical Industry Ltd.
―
Sumitomo Seika Chemicals Co., Ltd.
―
Dainichiseika Color & Chemicals Mfg.Co., Ltd.
―
Konishi Co., Ltd.
―
Options Prices
Currently, No data available
---